SMAD2 and non-small cell lung carcinoma: Our data indicates that XIST can promote proliferation and mediate chemoresistance to DDP in NSCLC by reducing the nuclear transfer of SMAD2, thereby inhibiting apoptosis and pyroptosis by blocking the transcription of p53 and NLRP3 respectively.